Onwudiwe v. Becerra

CourtDistrict Court, D. Maryland
DecidedAugust 18, 2023
Docket8:21-cv-01620
StatusUnknown

This text of Onwudiwe v. Becerra (Onwudiwe v. Becerra) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Onwudiwe v. Becerra, (D. Md. 2023).

Opinion

_ —

UNITED STATES DISTRICT COURT DISTRICT OF MARYLAND

NNEKA ONWUDIWE, Plaintiff, V. XAVIER BECERRA, Secretary, Civil Action No. TDC-21-1620 U.S. Department of Health and Human Services, Defendant.

MEMORANDUM OPINION Plaintiff Nneka Onwudiwe, a former employee of the United States Food and Drug Administration (“FDA”), a component agency of the United States Department of Health and Human Services, has filed suit against the Secretary of Health and Human Services (“HHS”), alleging race discrimination, a hostile work environment, and retaliation in violation of Title VII of the Civil Rights Act of 1964 (“Title VII”), 42 U.S.C. §§ 2000e-2000e-17 (2018), and retaliation in violation of the Family Medical and Leave Act (“FMLA”), 29 U.S.C. § 2615 (2018). HHS has filed a Motion to Dismiss, which is fully briefed. Having reviewed the submitted materials, the Court finds that no hearing is necessary. See D. Md. Local R. 105.6. For the reasons set forth below, HHS’s Motion will be GRANTED IN PART and DENIED IN PART. BACKGROUND Nneka Onwudiwe, a Black woman, was employed at HHS from August 12, 2012 until August 7, 2020. Between 2012 and 2014, Onwudiwe served as a Pharmacist at the FDA. Between 2014 and 2020, Onwudiwe served as a Consumer Safety Officer. During her time at the FDA,

_ —!—

Onwudiwe was supervised by various individuals, including Mark Askine, Robert Dean, Michael Sauers, Karen Rulli, and Twyla Thompson. Onwudiwe alleges that, during the time that she was employed at the FDA, she was subjected to race discrimination consisting of disparate treatment and a hostile work environment, in violation of Title VII, and unlawful retaliation in violation of both Title VII and the FMLA. In particular, Onwudiwe alleges that she was subjected to the following discriminatory conduct at the FDA: (1) the imposition of different guidelines for participation in outside activities; (2) deprivation of training opportunities; (3) threatening, humiliating, and intimidating conduct; (4) unfair criticism of her performance and negative performance evaluations; (5) the imposition of unfair work assignments and deadlines: (6) suspensions without pay; (7) stricter scrutiny of her time and credit hours; and (8) non-selection for various promotions. i Outside Activities and Training Opportunities In the presently operative Second Amended Complaint, Onwudiwe alleges that the FDA subjected her to stricter restrictions on participating in outside professional development activities than similarly situated colleagues who are not Black. Onwudiwe asserts that, beginning in May 2014, Onwudiwe’s supervisors “delayed and denied approval of” her requests to participate in such outside activities. Second Am. Compl. (“SAC”) 457, ECF No. 45. She further contends that Thompson, while her supervisor, required her to submit requests to participate in outside activities at least four months in advance, even though the agency generally recommended that such requests be submitted between six and eight weeks in advance. On at least one occasion, on July 24, 2019, Dean requested that Onwudiwe provide him with copies of the event invitation, final agenda, and all communications between Onwudiwe and the event organizer. Onwudiwe alleges that the

imposition of these heightened standards continued to occur on various occasions through her resignation in 2020. Relatedly, Onwudiwe alleges that beginning on August 7, 2014, her FDA supervisors “intentionally denied” her professional development and training opportunities that were afforded to similarly situated non-Black colleagues. /d. 58. In particular, Onwudiwe alleges that multiple FDA officials, including Dean, denied her participation in training sessions she wished to attend, or canceled such sessions in their entirety, before they were scheduled to occur on April 29, 2019, April 30, 2019, June 14, 2019, and July 29, 2019. II. Threatening, Humiliating, and Intimidating Conduct Onwudiwe also alleges that she was subjected to threatening, humiliating, and intimidating conduct by various coworkers and supervisors. She states that beginning in May 2014 and continuing throughout her time at the FDA, she was subjected to “humiliating, belittling, and disparaging comments” and “hurtful and destructive remarks and rumors” about her personality and conduct. /d. 43, 60. For example, on October 27, 2014, two of Onwudiwe’s coworkers, Breo Ellipta and Ellaine Cunnigham, described Onwudiwe in meeting minutes as “visually angry,” “increasingly angrier,” “raising her voice,” “eye rolling,” “head-shaking,” “smirking,” “sighing,” and “creat[ing] a tense and uncomfortable meeting environment.” /d §43. According to Onwudiwe, similarly situated non-Black employees were not described in meeting minutes in this way. Onwudiwe further asserts that on August 6, 2015, Thompson made “several comments threatening [Onwudiwe’s] job security.” /d. § 67. Likewise, Onwudiwe alleges that Dean in particular continuously subjected her to “harassment” and “threatening and intimidating behavior.” /d. § 141. According to Onwudiwe, on April 30, 2019, Dean “yelled at” Onwudiwe in an “angry tone.” /d. 4132. On June 24, 2019, Dean sent a “harassing and fear-inducing” email to

Onwudiwe relating to eligibility for the use of FMLA leave. /d. § 133. On November 26, 2019, Dean used an “elevated and forceful” tone with Onwudiwe when he stated, “I’m instructing you to answer my questions now” and “I’m going to have to force my hand.” Jd. § 166. Onwudiwe also alleges that Dean insisted that she meet with him one-on-one despite her “safety concerns.” Id. § 142. Onwudiwe alleges that similarly situated non-Black employees have not been subjected to the same kind of disparaging treatment. Ill. Criticism of Performance Onwudiwe also alleges that she was subjected to unfair criticism and reprimands and unjustifiably negative performance evaluations. She asserts that, beginning in May 2014, Dean and Rulli “continuously and unfairly” criticized her work. Jd. § 56. Onwudiwe alleges that she was subjected to verbal criticism of both individual projects and her overall performance on multiple occasions, including on the following dates: September 12, 2014; July 16, 2015; July 23, 2015; July 29, 2015; September 17, 2015; February 28, 2019; March 15, 2019; March 25, 2019; March 27, 2019; April 2, 2019; May 9, 2019; May 24, 2019; June 3, 2019; June 7, 2019; June 11, 2019; June 14, 2019; June 24, 2019; and December 4, 2019. Onwudiwe also asserts that she was subjected to written criticism of her work on both individual projects and her overall performance, including a written reprimand on January 18, 2018; written counseling memoranda on March 25, 2019 and March 27, 2019; and written reprimands on March 28, 2019 and April 1, 2019. Furthermore, Onwudiwe also asserts that she was subjected to unjustifiably negative formal performance evaluations, including a negative mid-year performance appraisal on July 23, 2015; an unfair performance evaluation, with a score of 3.16 out of 5, on January 28, 2016; an unfair performance evaluation, with a score of 3.83 out 5, on January 24, 2017; a negative performance evaluation on February 28, 2019; a negative performance evaluation on July 30,

2019; and a negative performance review, with a score of 2.17 out of 5, on March 17, 2020. According to Onwudiwe, supervisors threatened to place Onwudiwe on a Performance Improvement Plan on two occasions: Thompson made such a threat on July 29, 2015, and Dean made such a threat on July 30, 2019. Onwudiwe also alleges that, on several occasions, she did not receive credit, awards, or other recognition for the work she contributed.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Irwin v. Department of Veterans Affairs
498 U.S. 89 (Supreme Court, 1991)
Albright v. Oliver
510 U.S. 266 (Supreme Court, 1994)
Pennsylvania State Police v. Suders
542 U.S. 129 (Supreme Court, 2004)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Mosby-Grant v. City of Hagerstown
630 F.3d 326 (Fourth Circuit, 2010)
Louise L. Jenkins v. The Home Insurance Company
635 F.2d 310 (Fourth Circuit, 1980)
Gay v. Wall
761 F.2d 175 (Fourth Circuit, 1985)
Curtiss L. Cook v. Csx Transportation Corporation
988 F.2d 507 (Fourth Circuit, 1993)
Paul Carter v. William L. Ball, III
33 F.3d 450 (Fourth Circuit, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Onwudiwe v. Becerra, Counsel Stack Legal Research, https://law.counselstack.com/opinion/onwudiwe-v-becerra-mdd-2023.